RedChip Companies
|
Weekly Newsletter
|
|
|
Medigus Announces Record 2022 First Half Financial Results
|
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, reported financial results for the six months ended June 30, 2022.
Key Highlights Included:
- Generated record revenues of $34.95 million in the first half of 2022, compared to $2.39 million revenues in the first half of 2021
- Gross profit reached a record $6.19 million in the first half of 2022, up from a gross profit of $0.6 million in the first half of 2021
- Cash and cash equivalents as of June 30, 2022 were $22.1 million
- Shareholders’ equity improved to $53.19 million as of June 30, 2022, up from $51.43 million at December 31, 2021
“Our record first half of 2022 financial results are a direct result of our work over the past two years and clearly demonstrate the value in our approach to engage in innovative technology companies with high upside potential,” said Liron Carmel, CEO of Medigus. “As we continue to execute on our diversified business model and add value to our operating segments, we believe Medigus is in a great position to further grow shareholder value with multiple near-term catalysts.”
For more information, visit www.medigus.com
|
|
American Noble Gas Announces Initial Flow Rates and Helium Concentration From its First Production Well in the Hugoton Field
|
|
Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development, announced that it will present preclinical data on the potency of Lantern’s drug candidate LP-284 for mantle cell lymphoma (MCL) and several other non-Hodgkin’s lymphomas at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting, Sept. 28 – Oct. 1, 2022, in Houston, TX. Details of the poster presentation are listed below and can be found on the SOHO website. A full version of the poster will be available on Lantern’s website on October 3, 2022.
|
Siyata Mobile's Uniden(R) Cellular Booster Kits and Accessories To Be Purchased By U.S. Navy
Siyata Mobile Inc. (NASDAQ:SYTA)(NASDAQ:SYTAW), a global vendor of Push-to-Talk over Cellular (PoC) devices and cellular signal booster systems, announced that it has received a purchase order from a federal government contractor who will provide Uniden® cellular booster kits and accessories to the U.S. Navy. The order includes the Uniden® U70P Cellular Booster Kits and accessories that will be utilized for numerous naval buildings with poor cell phone signal reception.
"This is our first sale of cellular boosters that will be used by the military and we are extremely pleased to have been selected after a rigorous selection process. A significant benefit of this award is that Siyata has the solution to the Navy's cellular coverage issues, which we believe should create additional opportunities," said Siyata CEO Marc Seelenfreund.
|
|
|
Hempacco Expands Hemp Products Collaboration with HBI
Hempacco Co., Inc. (NASDAQ: HPCO), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, announced the expansion of its collaboration with RAW smoking paper innovators and wholesale distribution giant HBI International ("HBI") to manufacture its line of hemp wrap smoking rolling paper.
Highlights of the Hempacco & HBI Collaboration
- The introduction of HBI's new hemp wraps sold out in three hours
- HBI is one of the largest wholesale distributors of smoking products in the world
- Hempacco manufactures hemp wraps rolling smoking paper for HBI
- Hempacco is working with HBI's CEO Josh Kesselman and his research and development team to produce new hemp wrap flavor experiences and other hemp products
- HBI's flagship product RAW® rolling paper, is one of the most recognized names in Fast Moving Consumer Goods
- HBI sells products that reach over 100,000 retail locations
|
Growing Interest for Save Foods’ Innovative Eco-Treatments Among European Retailers and Distributors
Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, announced growing interest among European retailers and distributors in Save Foods innovative eco-treatment. As regulators and retailers across Europe move toward a "zero-tolerance" policy regarding pesticide residue limits, a growing number of European retailers and distributors are pursuing pilots with Save Foods to fight waste of fresh produce all along the food supply chain.
“Europe accounts for more than €60 billion (approximately $60 billion), or 44%, of the global trade value of fresh fruit and vegetables, and includes five of the 10 largest importing countries in the world. The feedback that we have received from distributors and retailers is extremely encouraging,” commented Dan Sztybel, CEO of Save Foods Ltd. “As large food suppliers continue to recognize the potential for Save Food's game changing treatments, we expect to see strong demand in the near and mid-terms”.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: OKYO - OKYO Pharma Limited |
4:15pm Eastern |
OKYO Pharma (OKYO) is a bio-pharmaceutical company focused on the discovery & development of first-in-class pharmaceutical therapies to treat inflammatory eye diseases including dry eye and ocular pain. |
|
|
|
|
OTCQB: QYOUF - QYOU Media Inc. |
4:15pm Eastern |
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
NASDAQ: HPCO - Hempacco Co., Inc.. |
4:15pm Eastern |
Hempacco Co, Inc. is Disrupting Tobacco™ and its nearly $1 trillion industry by manufacturing and selling herb and hemp smokables from San Diego, California. Through its own brands and joint venture businesses, the Company has launched various brands and products, including The Real Stuff, Hemp Hop with rapper Rick Ross, and Cheech & Chong's Hemp Smokables. |
|
|
|
|
OTCQB: OILCF - Permex Petroleum Corp |
4:15pm Eastern |
Permex Petroleum is a uniquely positioned junior Oil & Gas company with assets and operations across the Permian Basin of west Texas and the Delaware Sub-Basin of New Mexico. |
|
|
|
|
OTC: EMOR - Healixa, Inc. |
4:15pm Eastern |
Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
4:15pm Eastern |
Aridis Pharmaceuticals is a late-stage clinical development company, leading the creation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections. |
|
|
Archive Events |
|
|
|
NASDAQ: RNAZ - TransCode Therapeutic |
Meeting Duration 41 minutes |
TransCode Therapeutics is developing therapeutic and diagnostic candidates designed to deliver on the promise of RNA in oncology. The Company’s lead therapeutic candidate, TTX-MC138, targets microRNA-10b (miRNA-10b), a master regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovarian, colon cancer, glioblastomas and others. |
|
|
|
|
NYSE American: CANF - Can-Fite BioPharma Ltd. |
Meeting Duration 21 minutes |
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Psoriasis, and liver diseases including advanced liver cancer and NASH. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 30 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: LTRN - Lantern Pharma |
Meeting Duration 44 minutes |
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
|
|
NASDAQ: DPRO - Draganfly |
Meeting Duration 38 minutes |
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. |
|
|
Lesson of the Week
Are the markets random or predictable?
|
|
|
RedChip TV |
MidSouth Week in Review
Over the past nine trading days the S&P is down 10%.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
|
© 2022 RedChip , All rights reserved
|
|
|
|
|
|